CorVel director granted 1,500 stock options

CorVel Corp director Steven J. Hamerslag received a grant of 1,500 Non-Qualified Stock Options on August 6, 2026.

Rhea-AI Filing Summary

CorVel Corp director Steven J. Hamerslag received a grant of 1,500 Non-Qualified Stock Options on August 6, 2026. The options carry an exercise price of $62.45 per share and are exercisable in four equal annual installments beginning 12 months after the grant date, expiring on August 6, 2036. Following this grant, he holds options for 1,500 underlying shares directly.

Insider Trade Summary

Grant/Award: 1,500 shares

Grant/Award 1 txn

Insider HAMERSLAG STEVEN J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy) F1	1,500	$0.00	$0.00

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 1,500 contracts (Direct)

Footnotes (1)

1. F1. Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.

Key Figures

Options granted: 1,500 options Exercise price: $62.45 per share Underlying shares: 1,500 shares +2 more

5 metrics

Options granted 1,500 options Non-Qualified Stock Option grant on August 6, 2026

Exercise price $62.45 per share Conversion or exercise price of granted options

Underlying shares 1,500 shares CorVel common stock underlying the option grant

Expiration date August 6, 2036 Expiration of the Non-Qualified Stock Option grant

Options after transaction 1,500 options Total options held directly by reporting person following grant

Key Terms

Non-Qualified Stock Option, exercise price, underlying security, annual installments

4 terms

Non-Qualified Stock Option financial

"1,500 Non-Qualified Stock Options to purchase CorVel common stock"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

exercise price financial

"options carry an exercise price of $62.45 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

underlying security financial

"underlying security shares of CorVel common stock"

annual installments financial

"exercisable in four equal annual installments beginning 12 months after grant"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CorVel (CRVL) director Steven J. Hamerslag report in this Form 4?

Steven J. Hamerslag reported a grant of 1,500 Non-Qualified Stock Options to purchase CorVel common stock at an exercise price of $62.45 per share, expiring on August 6, 2036.

What is the exercise price of the options granted to the CorVel (CRVL) director?

The options granted to the CorVel director have an exercise price of $62.45 per share. This is the price at which he may purchase common shares when the options become exercisable.

How many CorVel (CRVL) shares underlie the options granted to Steven J. Hamerslag?

The option grant covers 1,500 underlying shares of CorVel common stock. After this grant, Hamerslag’s reported direct holdings in this option series total 1,500 options for 1,500 shares.

When do the newly granted CorVel (CRVL) options to the director vest?

The options vest in four equal annual installments, starting 12 months after the August 6, 2026 grant date. Each year, one-quarter of the 1,500 options becomes exercisable until fully vested.

What is the expiration date of the CorVel (CRVL) options granted to the director?

The granted options expire on August 6, 2036. After this date, any unexercised options will lapse, and the right to purchase CorVel common stock at $62.45 per share will terminate.

Are the CorVel (CRVL) director’s option transactions under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative. There is no footnote indicating that this specific option grant was made pursuant to a pre-arranged Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 03:45 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HAMERSLAG STEVEN J

(Last) (First) (Middle)

5128 APACHE PLUME ROAD, SUITE 400

(Street)

FORT WORTH TEXAS 75109

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CORVEL CORP [ CRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$62.45	08/06/2026		A		1,500		(1)	08/06/2036	Common Stock	1,500	$0.0	1,500	D

Explanation of Responses:

1. Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.

	By: Sharon O'Connor For: Steve Hamerslag	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)